Moolec Science (MLEC) Long-Term Deferred Tax (2023 - 2025)
Moolec Science (MLEC) reported Long-Term Deferred Tax of -$15.8 million for Q2 2025, up 21.26% on a YoY basis from -$13.0 million in Q2 2024, and up 21.26% sequentially from -$20.0 million in Q2 2024.
Moolec Science (MLEC) Long-Term Deferred Tax (2023 - 2025) Analysis & Trends
Moolec Science (MLEC) has 3 years of Long-Term Deferred Tax data on file, last reported at -$15.8 million in Q2 2025.
- For the quarter ending Q2 2025, Long-Term Deferred Tax rose 21.26% year-over-year to -$15.8 million; the trailing twelve-month figure through Jun 2025 stood at -$15.8 million (up 21.26% YoY), and the FY2025 full-year result was -$15.8 million, up 21.26% from the prior year.
- Long-Term Deferred Tax rose to -$15.8 million in Q2 2025, from -$20.0 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of -$15.8 million in Q2 2025 to a low of -$24.8 million in Q2 2023.
- A 3-year average of -$20.2 million and a median of -$20.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax climbed 19.38% in 2024 and rose 21.26% in 2025, its largest moves.
- Tracing MLEC's Long-Term Deferred Tax over 3 years: stood at -$24.8 million in 2023, then rose by 19.38% to -$20.0 million in 2024, then gained by 21.26% to -$15.8 million in 2025.
- Business Quant data shows MLEC's Long-Term Deferred Tax at -$15.8 million in Q2 2025, -$20.0 million in Q2 2024, and -$24.8 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,334.77 Bn | 68,334.48 Bn | - |
| 2 | Nanobiotix | 1,887.92 Bn | 1,887.86 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.16 Bn | 470.37 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.97 Bn | 115.73 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.33 Bn | 60.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.61 Bn | 62.61 Bn | - |
| 8 | Argenx Se | 57.10 Bn | 51.92 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.39 Bn | 38.39 Bn | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -15.77 Mn |
| Jun 30, 2024 | -20.02 Mn |
| Jun 30, 2023 | -24.84 Mn |